/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Differences in left anterior descending coronary artery disease in participants without standard modifiable cardiovascular risk factors: the Multi-Ethnic Study of Atherosclerosis (MESA)
Event: ESC Congress 2023
Topic: Epidemiology, Prognosis, Outcome
Session: Revascularisation of complex patients in stable coronary artery disease
Incorporating a polygenic risk score into cardiovascular disease examinations to identify subclinical coronary artery disease: rationale and design of the ESCALATE trial
Event: ESC Congress 2023
Topic: Prevention
Session: Risk prediction in stable coronary artery disease
Mirabegron in peripheral vascular disease: the STAR-PAD trial.
Event: ESC Congress 2022
Topic: Pharmacology and Pharmacotherapy
Session: Beta3 adrenergic agonists in the clinic: the end of the beginning
ESC 365 is supported by
